Pharmaceuticals and Biotech

Regulatory and reimbursement bottlenecks encouraging new business-models

The pharmaceutical industry is in a transformative phase with trends around value-based treatment, personalization and regulatory stringency. Evolving disease patterns towards chronic conditions in emerging markets, and aging population are other drivers for the industry. Companies are focusing more on R&D productivity, virtual clinical trials, and open innovation, while pricing pressures from biosimilars and generics remains a challenge.

Experience across the value chain

Our expertise across the product life cycle right from innovation R&D to Commercialization to life-cycle management will help you get a 360 degree view on future trends, market potential and positioning.

Experience across the value chain

Our expertise across the product life cycle right from innovation R&D to Commercialization to life-cycle management will help you get a 360 degree view on future trends, market potential and positioning.

     Select coverage areas

  • Clinical trial analytics
  • MOA and Target Identification
  • Epidemiology
  • Indication landscape
  • Technology scouting
  • Gene therapy services
  • Competitive landscape
  • Literative analysis
  • Evidence generation

Key issues the industry is grappling with today

What are the different models for value-based treatments in oncology in US?

What are the technologies available for releasing antibiotics through joint replacement implants for 4-8 weeks?

What are strategies and productivity benchmarks of US & EU-5 based small and medium size companies for “virtual clinical trials” ?

How competitors have had overcome the price barriers by applying cost sharing models in the treatment of cancer and diabetes through insulin in ‘out-of-pocket’ geographies ?

What is the market potential and the addressable patient pools for a novel drug in hemophilia A across US and Japan?

Who are the suitable partners in terms of capability, innovation, portfolio, geographic reach etc. for vaccine production?

Our Clients

 Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.

< >

Ready to talk to us about the challenges facing your business?

Leverage the potential of the Future.

Ready to talk to us about the

challenges facing your business?

Leverage the potential of the Future.